Factors influencing the hemodynamic and metabolic effects of insullin in muscle

Current Diabetes Reviews

Volumn 2, Issue 1, 2006, Pages 61-70

  Rattigan, Stephen ^a   Lei, Zhang ^a   Mahajan, Hema ^a   Kolka, Cathryn M ^a   Richards, Stephen M ^a   Clark, Michael G ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Blood flow; Capillary recruitment; Insulin action; Microvascular; Skeletal muscle

Indexed keywords

ADENOSINE; CYTOKINE; ENDOTHELIN; FATTY ACID DERIVATIVE; GLUCOSE; INSULIN; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

CAPILLARY FLOW; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; FEMORAL ARTERY FLOW; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEMODYNAMICS; HORMONE ACTION; HORMONE TRANSPORT; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEG BLOOD FLOW; LOW DRUG DOSE; MICROVASCULATURE; MUSCLE BLOOD FLOW; MUSCLE CAPILLARY; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

BLOOD FLOW VELOCITY; CAPILLARIES; DIABETES MELLITUS, TYPE 2; GLUCOSE; HEMODYNAMICS; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MICROCIRCULATION; MODELS, BIOLOGICAL; MUSCLE, SKELETAL;

EID: 33746107222     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339906775473653     Document Type: Review

References (100)

1. Baron AD, Laakso M, Brechtel G, Edelman SV. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 1991; 73:637-43.
2. Baron AD, Steinberg H, Brechtel G, Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 1994; 266:E248-E253.
3. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998; 41:369-79.
4. Utriainen T, Makimattila S, Virkamaki A, Bergholm R, Yki-Jarvinen H. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia 1996; 39:1477-82.
5. Natali A, Bonadonna R, Santoro D, et al. Insulin resistance and vasodilation in essential hypertension. Studies with adenosine. J Clin Invest 1994; 94:1570-6.
6. Clark MG, Colquhoun EQ, Rattigan S, et al. Vascular and endocrine control of muscle metabolism. Am J Physiol 1995; 268:E797-E812.
7. Dora KA, Colquhoun EQ, Hettiarachchi M, Rattigan S, Clark MG. The apparent absence of serotonin-mediated vascular thermogenesis in perfused. rat hindlimb may result from vascular shunting. Life Sci 1991; 48:1555-64.
8. Dora KA, Richards SM, Rattigan S, Colquhoun EQ, Clark MG. Scrotonin and norepinephrine vasoconstriction in rat hindlimb have different oxygen requirements. Am J Physiol 1992; 262:H698-H703.
9. Hellsten Y, Frandsen U, Orthenblad N, Sjodin B, Richter EA. Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. J Physiol (Lond) 1997; 498:239-48.
10. Rattigan S, Clark MG, Barrett EJ. Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 1997; 46:1381-8.
11. Rattigan S, Appleby GJ, Miller KA, et al. Serotonin inhibition of 1-methylxanthine metabolism parallels its vasoconstrictor activity and inhibition of oxygen uptake in perfused rat hindlimb. Acta Physiol Scand 1997; 161:161-9.
12. Rattigan S, Clark MG, Barrett EJ. Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes 1999; 48:564-9.
13. Jayaweera AR, Kaul S. Quantifying myocardial blood flow with contrast echocardiography. Am J Card Imaging 1993; 7:317-35.
14. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97:473-83.
15. Vincent MA, Dawson D, Clark AD, et al. Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes 2002; 51:42-8.
16. Dawson D, Vincent MA, Barrett EJ, et al. Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab 2002; 282:E714-E720.
17. Coggins M, Lindner J, Rattigan S, et al. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001; 50:2682-90.
18. Clark AD, Youd JM, Rattigan S, Barrett EJ, Clark MG. Heterogeneity of laser Doppler flowmetry in perfused muscle indicative of nutritive and nonmutritive flow. Am J Physiol 2001; 280:H1324-H1333.
19. Clark AD, Barrett EJ, Rattigan S, Wallis MG, Clark MG. Insulin stimulates laser Doppler signal by rat muscle in vivo consistent with nutritive flow recruitment. Clin Sci 2001; 100:283-90.
20. Clark MG, Clark ADH, Rattigan S. Failure of laser Doppler signal to correlate with total flow in muscle: Is this a question of vessel architecture? Microvasc Res 2000; 60:294-301.
21. Yang YJ, Hope ID, Ader M, Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 1989; 84:1620-8.
22. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 1985; 227:1583-6.
23. Steil GM, Ader M, Moore DM, Rebrin K, Bergman RN. Transendothelial insulin transport is not saturable in vivo - No evidence for a receptor-mediated process. J Clin Invest 1996; 97:1497-503.
24. Valensi P, Behar A, Cohen-Boulakia F, Valensi J, Wiemsperger N, Attali JR. In vivo kinetics of 123 iodine-labelled insulin in skeletal muscle of patients with type 2 diabetes. Effect of metformin. Diabetes Metab 2002; 28:95-103.
25. Muller M, Schmid R, Nieszpaur-Los M, et al. Key metabolite kinetics in human skeletal muscle during ischaemia and reperfusion: measurement by microdialysis. Eur J Clin Invest 1995; 25:601-7.
26. Holmang A, Muller M, Andersson OK, Lonnroth P. Minimal influence of blood flow on interstitial glucose and lactate-normal and insulin-resistant muscle. Am J Physiol 1998; 274:E446-E452.
27. Sjostrand M, Gudbjornsdottir S, Holmang A, Lonn L, Strindberg L, Lonnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes 2002; 51:2742-8.
28. Gudbjornsdottir S, Sjostrand M, Strindberg L, Lonnroth P. Decreased muscle capillary permeability surface area in type 2 diabetic subjects. J Clin Endocrinol Metab 2004; 90:1078-82.
29. Sjostrand M, Gudbjornsdottir S, Strindberg L, Lonnroth P. Delayed transcapillary delivery of insulin to muscle interstitial fluid after oral glucose load in obese subjects. Diabetes 2005; 54:152-7.
30. Halseth AE, Bracy DP, Wasserman DH. Functional limitations to glucose uptake in muscles comprised of different fiber types. Am J Physiol Endocrinol Metab 2001; 280:E994-E999.
31. Halseth AE, Bracy DP, Wasserman DH. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am J Physiol Endocrinol Metab 2000; 279:E1064-E1071.
32. Shulman GI. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda) 2004; 19:183-90.
33. Kim JK, Fillmore JJ, Sunshine MJ, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 2004; 114:823-7.
34. Clerk LH, Rattigan S, Clark MG. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002; 51:1138-45.
35. Youd JM, Rattigan S, Clark MG. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNFa. Diabetes 2000; 49:1904-9.
36. Wallis MG, Wheatley CM, Rattigan S, Barrett EJ, Clark ADH, Clark MG. Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes 2002; 51:3492-8.
37. de Jongh RT, Serne EK IJzerman RG, De Vries G, Stehouwer CD. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 2004; 53:2873-82.
38. Clerk LH, Vincent MA, Lindner JR, Clark MG, Rattigan S, Barrett EJ. The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev 2004; 20:3-12.
39. Renkin EM. Effects of blood flow on diffusion kinetics in isolated, perfused hindlegs of cats: A double circulation hypothesis. Am J Physiol 1955; 183:125-36.
40. Rabkin R, Reaven GM, Mondon CE. Insulin metabolism by liver, muscle, and kidneys from spontaneously diabetic rats. Am J Physiol 1986; 250:E530-E537.
41. Bonadonna RC, Saccomani MP, Del Prato S, Bonora E, Defronzo RA, Cobelli C. Role of tissue-specific blood flow and tissue recruitment in insulin- mediated glucose uptake of human skeletal muscle. Circulation 1998; 98:234-41.
42. Vincent MA, Clerk LH, Lindner JR, et al. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 2004; 53:1418-23.
43. Zhang L, Vincent MA, Richards SM, et al. Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 2004; 53:447-53.
44. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94:1172-9.
45. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94:2511-5.
46. Cleland SJ, Petrie JR, Small M, Elliott HL, Connell JM. Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 2000; 35:507-11.
47. Coggins M, Lindner J, Rattigan S, et al. Physiologic byperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001; 50:2682-90.
48. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003; 285:E123-E129.
49. Shankar R, Zhu JS, Ladd B, Henry D, Shen HQ, Baron AD. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest 1998; 102:1403-12.
50. Mahajan H, Richards SM, Rattigan S, Clark MG. Local infusion of an inhibitor of Ca2+-dependent K+ channels (TEA), but not L-NAME blocks insulin-mediated capillary recruitment and glucose uptake in muscle in vivo. Diabetes 2005; 54:Abstract in press.
51. Mahajan H, Richards SM, Rattigan S, Clark MG. Local methacholine but not bradykinin potentiates insulin-mediated glucose uptake in muscle in vivo by augmenting capillary recruitment. Diabetologia 2004; 47:2226-34.
52. de Jongh RT, Clark AD, IJzerman RG, Serne EH, De Vries G, Stehouwer CD. Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers. Diabetologia 2004; 47:978-86.
53. Sarabi M, Lind L, Millgard J, et al. Local vasodilatation with metacholine, but not with nitroprusside, increases forearm glucose uptake. Physiol Res 1999; 48:291-5.
54. Natali A, Quinones GA, Pecori N, Sann G, Toschi E, Ferrannini E. Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension. Hypertension 1998; 31:632-6.
55. Clark MG, Wallis MG, Barrett EJ, et al. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 2003; 284:E241-E258.
56. Clerk LH, Smith ME, Rattigan S, Clark MG. Increased chylomicron triglyceride hydrolysis by connective tissue flow in perfused rat hindlimb. Implications for lipid storage. J Lipid Res 2000; 41:329-35.
57. Song MY, Ruts E, Kim J, Janumala, I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 2004; 79:874-80.
58. Kesavadev JD, Short KR, Nair KS. Diabetes in old age: an emerging epidemic. J Assoc Physicians India 2003; 51:1083-94.:1083-94.
59. Chen YL, Messina EJ. Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am J Physiol 1996; 270:H2120-H2124.
60. Zeng GY, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin - Direct measurement in vascular endothelial cells. J Clin Invest 1996; 98:894-8.
61. Delaney CA, Murchie KJ, Westerman RA, de Court. Rapid actions of insulin on sensory nerve function. Neuroreport 1998; 9:2775-9.
62. Serne EH, IJzerman RG, Gans RO, et al. Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia. Diabetes 2002; 51:1515-22.
63. Eringa EC, Stehouwer CD, Merlijn T, Westerhof N, Sipkema P. Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc Res 2002; 56:464-71.
64. Vicent D, Ilany J, Kondo T, et al. The role of endothelial insulin signalin in the regulation of vascular tone and insulin resistance. J Clin Invest 2003; 111:1373-80.
65. Goetze S, Kintscher U, Kawano H, et al. Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cells. J Biol Chem 2000; 275:18279-83.
66. Sowers JR, Standley PR, Ram JL, Zemel MB, Resnick LM. Insulin resistance, carbohydrate metabolism and hypertension. Am J Hypertens 1991; 4:466S-72S.
67. Utriainen T, Nuutila P, Takala T, et al. Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 1997; 100:777-85.
68. Fryer LG, Hajduch E, Rencurel F, et al. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000; 49:1978-85.
69. Rocchini AP, Moorehead C, Katch V, Key J, Finta KM. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension 1992; 19:615-20.
70. Kennedy JW, Hirshman MF, Gervino EV, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48:1192-7.
71. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:771-6.
72. Natali A, Baldeweg S, Toschi E, et al. Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care 2004; 27:1349-57.
73. Tack CJ, Ong MK, Lutterman JA, Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998; 41:569-76.
74. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JM. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996; 93:1331-3.
75. Frisbee JC, Stepp DW. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol 2001; 281:H1304-H1311.
76. Utriainen T, Makimattila S, Virkamaki A, Lindholm H, Sovijarvi A, Yki-Jarvinen H. Physical fitness and endothelial function (nitric oxide synthesis) are independent determinants of insulin-stimulated blood flow in normal subjects. J Clin Endocrinol Metab 1996; 81:4258-63.
77. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267:E187-E202.
78. Clerk LH, Rattigan S, Clark MG. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002; 51:1138-45.
79. Zhang L, Wheatley CM, Richards SM, Barrett EJ, Clark MG, Rattigan S. TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction. Am J Physiol Endocrinol Metab 2003; 285:E654-E660.
80. Suvorava T, Lauer N, Kojda. G. Physical inactivity causes endothelial dysfunction in healthy young mice. J Am Coll Cardiol 2004; 44:1320-7.
81. Gill JM, Al Mamari A, Ferrell WR, et al. Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol 2004; 44:2375-82.
82. Wojtaszewski JF, Jorgensen SB, Frosig C, MacDonald C, Birk JB, Richter EA. Insulin signalling: effects of prior exercise. Acta Physiol Scand 2003; 178:321-8.
83. Cook S, Hugli O, Egli M, et al. Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 2004; 53:2067-72.
84. Rattigan S, Wallis MG, Youd JM, Clark MG. Exercise training improves insulin-mediated capillary recruitment in association with glucose uptake in rat hind limb. Diabetes 2001; 50:2659-65.
85. Rattigan S, Dora KA, Colquhoun EQ, Clark MG. Serotonin-mediated acute insulin resistance in the perfused rat hindlimb but not in incubated muscle: a role for the vascular system. Life Sci 1993; 53:1545-55.
86. Rattigan S, Dora KA, Colquhoun EQ, Clark MG. Inhibition of insulin-mediated glucose uptake in rat hindlimb by an alpha-adrenergic vascular effect. Am J Physiol 1995; 268:E305-E311.
87. Plusczyk T, Bersal B, Menger MD, Feifel G. Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation. Dig Dis Sci 2001; 46:1343-51.
88. de Nucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85:9797-800.
89. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 2001; 41:851-76.:851-76.
90. McEniery CM, Wilkinson IB, Jenkins DG, Webb DJ. Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension 2002; 40:202-6.
91. Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO, Baron AD. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002; 51:3517-23.
92. Rich S, McLaughlin VV. Endothelin receptor blockers in cardiovascular disease. Circulation 2003; 108:2184-90.
93. Cardillo C, Nambi SS, Kilcoyne CM, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100:820-5.
94. Eringa EC, Stehouwer CD, Merlijn T, Westerhof N, Sipkerna P. Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc Res 2002; 56:464-71.
95. Verma S, Yao L, Stewart DJ, Dumont AS, Anderson TJ, McNeill JH. Endothelin antagonism uncovers insulin-mediated vasorelaxation in vito and in vivo. Hypertension 2001; 37:328-33.
96. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 1997; 161:211-20.
97. Ferri C, Carlomagno A, Coassin S, et al. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 1995; 18:226-33.
98. Idris I, Patiag D, Gray S, Donnelly R. Tissue- and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake. Biochem Pharmacol 2001; 62:1705-8.
99. Kolka CM, Rattigan S, Richards SM, Clark MG. Endothelin-1 as a messenger for insulin has both stimulatory and inhibitory effects on perfused muscle metabolism via its vascular actions. Diabetes 2004; 53:A368.
100. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with Type II diabetes mellitus. Circulation 2002; 106:1783-7.